February 7, 2017 @ 5:55 pm | ALV, Breaking News, Jubak Picks Portfolio, Update |
Whew! And Yay! Whew, that it looks like someone else is going to win the bidding to acquire what’s left of airbag maker and Autoliv competitor Takata. Yay, that the likely acquirer is an airbag maker owned by China’s Ningbo Joyson Electronic. I’m...
January 9, 2017 @ 11:24 pm | Breaking News, INCY, Jubak Picks Portfolio, Update |
Incyte (INCY) ended 2016 with a big deal. The company agreed to pay Merus (MRUS) $120 million and to buy $80 million in Merus stock for the exclusive rights to 11 bispecific antibody programs. The companies will work together to develop and commercialize these...
January 4, 2017 @ 11:59 pm | ACAD, Jubak Picks Portfolio, Update |
Update January 4. Shares of Acadia Pharmaceuticals (ACAD) were up 12% this morning, January 4, before closing with a gain of 11.02% to $31.94. The action came on rumors that Pfizer (PFE) or another big drug company would make a bid for the biotech on the strength of...
December 30, 2016 @ 3:00 pm | Breaking News, Jubak Picks Portfolio, SFTBY, Update |
Update December 30,2016. Softbank (SFTBY) has been in the headlines a lot recently–usually after an announcement by President-elect Donald Trump. There was Softbank CEO and chairman Masayoshi Son emerging after a meeting with Trump at Trump Tower to announce...
December 9, 2016 @ 7:07 pm | Jubak Picks Portfolio, LNG, Update |
Update December 9, 2016 The Cheniere Energy story is pretty simple. The company got the first license to export liquified natural gas from the United States, locked in long-term contracts for its Sabine Pass and Corpus Christi terminals, and then waited for revenue to...
December 9, 2016 @ 1:59 pm | Jubak Picks Portfolio, SWC |
Stillwater Mining (SWC) has agreed to an acquisition offer from South Africa’s Sibanye Gold (SBGL.) The proposed purchase price of $2.2 billion works out to $18.00 a share for the largest primary producer of platinum and palladium outside of South Africa and...
December 5, 2016 @ 6:37 pm | Buy, Jubak Picks Portfolio, VMC |
When big macro news comes down the pike that promises to change the fundamentals in a sector, frequently the stocks that rally hardest are those that belong to the most “endangered” companies. Which doesn’t mean those are the shares that you want to...
November 22, 2016 @ 10:53 am | AGN, Jubak Picks Portfolio, Sell |
I still like Allergan’s (AGN) portfolio of anti-aging drugs, especially it’s Botox franchise. But I’m not especially fond of the company’s current strategy of acquisitions in the very hot market for NASH drugs. Yes, someone will win a key...
November 18, 2016 @ 7:32 pm | IONS, Jubak Picks Portfolio, Update |
Sometimes the importance of a clinical trial extends way beyond the specific drug under study. That’s the case with the Phase II data recently released by Ionis for FIXRx. The trial did show efficacy in the treatment of kidney disease. But the most important...
November 17, 2016 @ 7:33 pm | INCY, Jubak Picks Portfolio, Update |
Incyte (INCY) has been one of the big movers in the biotech rally after Donald Trump’s victory in the November 8 presidential election. The stock is up 26.7% from the close on November 3 to the close today, November 17. (Incyte is a member of my Jubak Picks...
November 16, 2016 @ 7:55 pm | Jubak Picks Portfolio, Sell, SH, Volatility |
It looks like the third quarter saw the end of the long earning recession for Standard & Poor’s 500 companies. That recession had seen earnings for the S&P 500 companies drop for five straight quarters. With more than 90% of the S&P 500 companies...
November 15, 2016 @ 7:52 pm | ACAD, Buy, Jubak Picks Portfolio |
The big test for Acadia Pharmaceuticals (ACAD) this quarter certainly wasn’t earnings. As an early stage biotech losses are expected and that’s exactly what the company delivered when it reported third quarter results on November 7. The loss came to 61...
November 15, 2016 @ 5:10 pm | BMY, Breaking News, Jubak Picks Portfolio, Update |
Back on August 8 Bristol-Myers Squibb (BMY) announced that its key immuno-oncology drug Opdivo had failed to demonstrate its efficacy in a trial for treating lung cancer. At the time I characterized this particular trial as a part of a go-for-broke strategy that would...
November 8, 2016 @ 2:00 pm | Breaking News, Jubak Picks Portfolio, MGM, Update |
MGM Resorts International (MGM) hit a new 52-week high during intraday trading on November 7. The stock is now up 119.96% since I added it to my Jubak Picks portfolio back on May 4, 2012. Shouldn’t I just take my profits and run? Well, Yes if all the catalysts...
October 31, 2016 @ 7:14 pm | IEF, Jubak Picks Portfolio, Sell |
When I bought shares of the iShares 7-10 Year Treasury Bond ETF (IEF) back on June 28, 2016, it was in the belief that the Federal Reserve would raise interest rates (as early as September or as late as December) while other central banks remained committed to their...
October 20, 2016 @ 7:53 pm | ITUB, Jubak Picks Portfolio, Update |
Yesterday the Banco Central do Brasil reduced Brazil’s benchmark Selic interest rate for the first time in four years. The cut, 25 basis points to 14%, was less than the 50 basis points the market was hoping for. But the dream is that it will be just the first...
October 13, 2016 @ 7:44 pm | ABT, Jubak Picks Portfolio, Sell |
Back on September 20 I questioned whether management at Abbott Laboratories had the skills to execute a growth through acquisitions strategy. At the time the company was–and it still is–involved in a dispute with Allere (ALR) over whether that company had...
September 26, 2016 @ 7:46 pm | ITUB, Jubak Picks Portfolio, Update, Volatility |
Update September 26, 2016 Could Brazil see the first interest rate cut since 2012 in October? With the Banco Central do Brasil’s benchmark Selic interest rate at 14.25% there’s certainly plenty of room. And even though the country’s politics are a...
September 23, 2016 @ 7:39 pm | AGN, Jubak Picks Portfolio, Update |
Update September 23, 2016 Allergan (AGN), which I added to my Jubak’s Picks portfolio on July 30, 2015 on the strength of its Botox franchise, acquired two companies on September 20. Neither is in the Botox or cosmetic drugs space. Both, in fact, are companies...
September 21, 2016 @ 7:04 pm | BMY, Jubak Picks Portfolio, Update |
Update September 21. Let’s be clear about what happened to Bristol-Myers Squibb (BMY) and its key immuno-oncology drug Opdivo on Friday, August 8, when the company announced that Opdivo had failed to demonstrate its efficacy in a trial for treating lung cancer....
September 2, 2016 @ 7:44 pm | Breaking News, Jubak Picks Portfolio |
I’ve never liked doing all the calculations required to figure out the performance of my Jubak’s Picks portfolio. Frankly, figuring out the exact gains in positions that have, because of history, come to have radically different numbers of shares and then...
August 18, 2016 @ 7:30 pm | COF, Jubak Picks Portfolio, Sell |
There’s really nothing wrong with the shares of Capital One Financial (COF) that a stronger U.S. economy, a more confident U.S.consumer, and an interest rate increase–or two–from the Federal Reserve wouldn’t fix. It’s just that I...
August 11, 2016 @ 5:23 pm | BABA, Jubak Picks Portfolio, Update |
Update: August 11, 2016. Okay, the top line numbers were impressive. Today Alibaba Group Holding (BABA) reported a 59% increase in revenue for its June quarter. But for the first time Alibaba provided segment details on its various businesses–due at least in...
July 22, 2016 @ 11:05 pm | Jubak Picks Portfolio, Volatility |
The Jubak’s Picks, my 12-18 month portfolio, lost 2.3% for 2011. That trailed the 2.1% return for the Standard & Poor’s 500 Index during the year. The problem for the portfolio was my inability to stay nimble enough to navigate the market’s volatility in 2011. Or...
July 12, 2016 @ 7:40 pm | Jubak Picks Portfolio |
Update July 12. The yield on 10-year Treasuries rose to 1.52%, the highest level this month (and prices fell). Last week the yield on the 10-year Treasury hit a record low of 1.318%. The climb in Treasury yields is likely to be temporary, in my opinion. The market is...
July 6, 2016 @ 5:19 pm | Jubak Picks Portfolio |
On my paid site JubakAM.com I aim for a mix of posts on macro trends and on individual stock picks. It’s a strategy I call tactical stock picking. Over the last few days on this free site and on my paid site, I’ve posted my views on the short-term and...
July 4, 2016 @ 2:15 pm | ALV, Jubak Picks Portfolio |
April 29th, 2016 When back on March 29 I gave a thumbs up to Autoliv (ALV) in a post on my subscription JubakAM.com site as a pick for the increasing automaker emphasis upon safety and driver-assisted or autonomous driving systems, I said I’d like to wait until after...
April 9, 2016 @ 11:38 am | ALV, Jubak Picks Portfolio, Recent Buys |
When back on March 29 I gave a thumbs up to Autoliv (ALV) in a post on my subscription JubakAM.com site as a pick for the increasing automaker emphasis upon safety and driver-assisted or autonomous driving systems, I said I’d like to wait until after the company’s...
December 9, 2015 @ 3:58 pm | COF, Jubak Picks Portfolio |
Financial stocks tend to do well as interest rates rise. What you’re looking for in this environment is a bank stock that is likely to show an increasing net interest margin. Like Capital One Financial (COF). In the third quarter net interest margin rose to 6.73%, up...
June 30, 2010 @ 6:28 pm | Jubak Picks Portfolio, Leading Indicators |
The Jubak’s Picks, my 12-18 month portfolio, returned a paltry 0.7% in the first quarter of 2010. Since today, June 30, marks the close of the second quarter of 2010, I guess you can say I’m little behind in reporting the performance of Jubak’s Picks. In fact I’m...